Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Dietrich, A. Barankay, G. Dilthey, R. Henze, E. Niekau, F. Sebening, J. Richter (1989)
Reduction of Homologous Blood Requirement in Cardiac Surgery by Intraoperative Aprotinin Application - Clinical Experience in 152 Cardiac Surgical PatientsThe Thoracic and Cardiovascular Surgeon, 37
G. Fraedrich, C. Weber, C. Bernard, A. Hettwer, V. Schlosser (1989)
Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary ResultsThe Thoracic and Cardiovascular Surgeon, 37
van Oeveren, L. Eijsman, K. Roozendaal, C. Wildevuur (1988)
PLATELET PRESERVATION BY APROTININ DURING CARDIOPULMONARY BYPASSThe Lancet, 331
R. Becker, J. Alpert (1990)
The impact of medical therapy on hemorrhagic complications following coronary artery bypass grafting.Archives of internal medicine, 150 10
W. Dietrich, M. Jochum, W. Schramm, G. Blümel, J. Richter (1989)
REDUCTION OF HOMOLOGOUS BLOOD REQUIREMENT IN CARDIAC SURGERY USING HIGH DOSE APROTININAnesthesiology, 71
D. Royston, K. Taylor, B. Bidstrup, R. Sapsford (1987)
EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERYThe Lancet, 330
W. Oeveren, Marcel Harder, K. Roozendaal, L. Eijsman, C. Wildevuur (1990)
Aprotinin protects platelets against the initial effect of cardiopulmonary bypass.The Journal of thoracic and cardiovascular surgery, 99 5
C. Markland, M. Sturridge, J. Hulf, N. Woodall (1988)
EFFECT OF APROTININ ON BLOOD LOSS IN REPEAT OPEN-HEART SURGERYThe Lancet, 331
B. Bidstrup, D. Royston, R. Sapsford, K. Taylor, D. Cosgrove (1989)
Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol).The Journal of thoracic and cardiovascular surgery, 97 3
Abstract To the Editor.— We read with interest the excellent review article by Becker and Alpert1 in the October 1990 issue of the Archives. In our opinion, it might be useful that the readers of the Archives be provided with some data concerning aprotinin (Trasylol, Bayer AG, Leverkusen, Federal Republic of Germany), a drug available in most European countries and used for the treatment of hyperfibrinolytic hemorrhage and other indications, even though this drug is not registered in the United States.Aprotinin is a basic polypeptide, obtained from bovine lung. By forming reversible stoichiometric enzyme—inhibitor complexes, it acts as an inhibitor of human trypsin, plasmin, plasma, and tissue kallikrein. In 1987, Royston et al2 reported reduced blood loss and blood use in repeated coronary artery bypass grafting, due to the use of high doses of aprotinin (about 840 mg) during surgery. The decrease of postoperative bleeding was sufficient to ensure References 1. Becker C, Alpert S. The impact of medical therapy on hemorrhagic complication following coronary artery bypass grafting . Arch Intern Med. 1990;150:2016-2021.Crossref 2. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusions after repeat open heart surgery . Lancet. 1987;2:1289-1291.Crossref 3. Bidstrup BP, Royston D, Sapsford RN, Taylor KM. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol) . J Thorac Cardiovasc Surg. 1989;97:364-372. 4. Fraedrich G, Weber C, Bernard A, Hettwer A, Schlosser V. Reduction of blood transfusion requirement in open heart surgery by administration of high dose aprotinin: preliminary results . Thorac Cardiovasc Surg. 1989;37:89-91.Crossref 5. Dietrich W, Barankay A, Dilthey G, et al. Reduction in homologous blood requirement in cardiac surgery by intraoperative aprotinin application: clinical experience in 152 cardiac surgical patients . Thorac Cardiovasc Surg. 1989;37:92-98.Crossref 6. Van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass . J Thorac Cardiovasc Surg. 1990;99:788-797. 7. Markland CG, Sturridge MF, Hulf GF, Woodal NM. Effect of aprotinin on blood loss in repeat open heart surgery . Lancet. 1988;1:711.Crossref 8. Dietrich W, Jochum M, Schramm W, Blümel G, Richter JA. Reduction in homologous blood requirement in cardiac surgery using high dose aprotinin . Anesthesiology. 1989;71:7. Abstract.Crossref 9. Van Oeveren W, Eijsman L, Roozendaal KJ, Wildevuur CRH. Platelet preservation by aprotinin during cardiopulmonary bypass . Lancet. 1988;1:644.Crossref
Archives of Internal Medicine – American Medical Association
Published: Jul 1, 1991
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.